Mankind Pharma shares jump 8% as Q2 profit rises 38% to Rs 716 crore
60-Word AI Digest
Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, supported by domestic and export growth, while EBITDA margins expanded 210 basis points.
Key Takeaways
- Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore.
- Revenue grew 17%, supported by domestic and export growth, while EBITDA margins expanded 210 basis points.
- Full details and original dispatch available below.
Mankind Pharma shares jumped nearly 8% after the company reported a 38% year-on-year rise in Q2 profit to Rs 716 crore. Revenue grew 17%, supported by domestic and export growth, while EBITDA margins expanded 210 basis points.
Original Publisher Attribution
This summary was curated from Economic Times.